FOSKX | RERAX | FOSKX / RERAX | |
Total Expense Ratio | 0.59 | 1.57 | 38% |
Annual Report Gross Expense Ratio | 0.59 | 1.57 | 38% |
Fund Existence | 17 years | 23 years | - |
Gain YTD | 19.621 | 12.433 | 158% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.31B | 134B | 5% |
Annual Yield % from dividends | 1.53 | 0.23 | 652% |
Returns for 1 year | 15.00 | 4.08 | 367% |
Returns for 3 years | 59.86 | 26.81 | 223% |
Returns for 5 years | 55.31 | 12.35 | 448% |
Returns for 10 years | 84.96 | 21.06 | 403% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AICFX | 63.37 | 0.61 | +0.97% |
American Funds Invmt Co of Amer F1 | |||
GSVSX | 16.50 | 0.13 | +0.79% |
Goldman Sachs Large Cap Value Svc | |||
EKGAX | 37.87 | 0.11 | +0.29% |
Allspring Special Global Small Cap A | |||
JFNSX | 62.64 | 0.05 | +0.08% |
Janus Henderson Global Life Sciences S | |||
LLPFX | 25.01 | -0.04 | -0.16% |
Longleaf Partners |